NASDAQ:IOBT
Delisted

Io Biotech Stock Signals

etoro logo Buy IOBT
*Your capital is at risk
$0.0480
+0 (+0%)
At Close: Jul 08, 2026

Latest Data & Signals Issued

Below are some of the latest signals issued for IO Biotech, Inc.

General

Signal Type Signal Value Data
Score 0.000 63 days ( -182.35 %
Last Price $0.0480 0 %
Performance History
7 Days
$0.0480 $0.0480
0%
30 Days
$0.0480 $0.0480
0%
12 Mos
$1.45 $0.0480
-96.69%

4/18

Active Buy Signals

Specific Signals

Short Term
Net score: 54.73
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0480 - $0.0480
Trend - 3 mos 7.15 % High Width: 220.28 %
Pred. range - 3 mos $0.0168 - $0.0537 Low -65.06 % - 11.92 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Sell Very Low Jul 07, 2026 - 2 days
RSI Short Pivot Signal Sell Very Low Apr 22, 2026 - 53 days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Buy Medium May 18, 2026 - 35 days
Short/Long MA 3 mos Buy Medium May 18, 2026 - 35 days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 25.98
Signal Type Signal Value Importance Data
Trend - 12 mos -82.61 % Very High Width: 135.54 %
Pred. range - 12 mos N/A - $0.0758 High -100.00 % - 57.95 %
Short MA 12 mos Buy Very High Apr 28, 2026 - 49 days
Long MA 12 mos Sell Very High Sep 25, 2025 - 196 days
Short/Long MA 12 mos Sell Very High Sep 30, 2025 - 193 days
Pivot Long Sell Low Jul 07, 2026 - 2 days
RSI Long Pivot Signal Sell Low May 01, 2026 - 46 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT IO BIOTECH, INC.
IO Biotech
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 2 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and ne...
GOLDEN STAR
Ticker Change Signal Date
FCX
$62.63
7.46% Jul 31
MC
$67.08
2.40% Jul 31
ARW
$212.85
6.96% Jul 30
BIIB
$202.19
3.10% Jul 24
F
FERG
$230.67
10.77% Jul 24

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE